IL2 and cancer: Other cancer immunotherapy strategies have also emerged, including cancer vaccines targeting tumor-specific antigens, cytokine therapies (e.g., IL-2 and IFN-α for melanoma and renal cancer), and cell therapies, such as CAR-T, which has revolutionized the treatment of hematologic malignancies like B-cell acute lymphoblastic leukemia and multiple myeloma [58].